$17.68 -0.08 (-0.45%)
2/9/2010 4:00 PM

Mylan Laboratories, Inc. (MYL)

CAPS Rating: 3 out of 5

The Company develops, licenses, manufactures, markets and distributes generic, brand and branded generic pharmaceutical products and active pharmaceutical ingredients.

Current Price $17.68 Mkt Cap $5.4B
Open $17.80 P/E Ratio 111.00
Prev. Close $17.76 Div. (Yield) 0.24 (1.20%)
Daily Range $17.54 - $17.96 Volume 5,953,376
52-Wk Range $11.14 - $19.21 Avg. Daily Vol. 0

MYL News and Commentary

Caps

How do you think MYL will perform vs the S&P 500?

Add Stock to Watchlist

All Members

510 Outperform
38 Underperform
 

All-Star Members

160 Outperform
8 Underperform
 

Wall Street

16 Outperform
1 Underperform
 

Top MYL Bull/Bear Pitches

The best Bull and Bear pitches based on recency and number of recommendations.

RXDOC73 (99.30)
Submitted October 28, 2008

The population is just getting older and more people are going to need more drugs. There is a great deal of consolidation in the field and only the strong companies like this one will survive the fallout.

Also a great takeover target for… More

1 Comment | Reply | Report this Post

DouglasRich (< 20)
Submitted January 29, 2008

Mylan is known for making good quality, reliable generic pharmaceutical products, but I think their primary drawback is they haven't found a way to outcompete the generic market. In the pharmacy, cheaper generics are preferred to Mylan's oftentimes… More

1 Comment | Reply | Report this Post
MYL VS S&P 500 (SPY)

Recent Community Commentary

Read the most recent pitches from members about MYL.

Recs

0
Member Avatar zhilmi (31.53) Submitted: 1/28/2010 11:24:14 PM : Outperform Start Price: $18.01 MYL Score: -0.16

Generics, nice line of meds, improving stats

Report this Post 0 Comments | Reply | Permalink

Recs

0
Member Avatar dutchredneck (59.37) Submitted: 9/23/2009 10:30:55 AM : Outperform Start Price: $16.11 MYL Score: +9.60

Growth stock will outperform the S&P.

Report this Post 0 Comments | Reply | Permalink

Recs

0
Member Avatar 8tune (55.78) Submitted: 9/9/2009 1:46:27 PM : Outperform Start Price: $14.27 MYL Score: +20.13

Mylan generic pharma to outperform S&P.

Report this Post 0 Comments | Reply | Permalink
View All 89 Pitches »

Leaderboard

Find the members with the highest scoring picks in MYL.

Score Leader

Allakazam

Allakazam (99.64) Score: +160.77

The Score Leader is the member with the highest score across all their picks in MYL.

Top
Pick 		Member Name Member
Rating 		Start
Date 		Call Time
Frame 		Start
Price 		Stock
Gain 		S&P
Gain 		Score Commentary
Allakazam 99.64 10/27/2008 Outperform NS $6.14 +187.95% +27.18% +160.77
DustinCody 99.69 10/24/2008 Outperform NS $6.25 +182.88% +27.33% +155.55
csbdorado 93.88 10/23/2008 Outperform NS $7.07 +150.07% +21.58% +128.49
bernleeds 58.01 10/21/2008 Outperform 1Y $7.81 +126.38% +14.35% +112.02
jmoney14 33.27 10/6/2008 Outperform 1Y $8.01 +120.72% +8.73% +111.99
This player feels very strongly about this pick and has marked it a Top Pick. Top Picks do not affect a player’s score. biotech4ever 91.93 10/30/2008 Outperform 5Y $8.00 +121.01% +16.19% +104.82 1 Comment
Piner75 68.59 10/20/2008 8/3/2009 Outperform 1Y $8.20 +115.61% +14.02% +101.59
matu2009 83.39 11/20/2008 Outperform 3Y $7.72 +129.02% +37.28% +91.73 1 Comment
HahaCAPS 93.54 10/6/2008 Outperform NS $8.95 +97.54% +6.03% +91.51
tiobueno 97.97 3/7/2008 Outperform NS $10.19 +73.50% -14.12% +87.63 1 Comment
View Complete Scorecard »

Wall Street

See what the Wall Street professionals think, according to their public statements and filings.

Member Name Member
Rating		 Start
Date		 Call Time
Frame		 Start
Price		 Stock
Gain		 S&P
Gain		 Score End Date Commentary
TrackSunTrustRH 87.33 12/10/2009 Outperform NS $18.32 -3.49% -3.14% -0.35
TrackRBCCapMkts 86.33 4/23/2009 Outperform NS $14.49 +22.02% +27.91% -5.89
TrackBarclaysCap 94.50 2/23/2009 Outperform NS $12.99 +36.10% +39.42% -3.31
TrackStanfordRes 85.54 9/25/2008 Outperform NS $12.02 +47.09% -7.95% +55.04
TrackNeedham 67.64 9/25/2008 Outperform NS $12.02 +47.09% -7.95% +55.04
TrackCarisandCo 86.28 6/13/2008 Outperform NS $12.56 +14.25% -23.31% +37.56 9/9/2009 @ $14.35
TrackScottBleier 91.98 6/13/2008 Outperform 3M $12.59 +40.43% -18.33% +58.76
TrackBerkowitz 83.78 5/27/2008 Outperform 1Y $12.58 -36.57% -40.87% +4.30 11/24/2008 @ $7.98 2 Comments
TrackSoros 82.58 3/31/2008 Outperform NS $11.60 +52.41% -15.75% +68.16 1 Comment
TrackCitigroup 85.92 3/14/2008 Outperform NS $11.17 +58.28% -15.84% +74.12
TrackPatDorsey 92.89 1/4/2008 Outperform 5Y $13.69 +29.15% -20.92% +50.07
TrackBofASec 94.61 12/18/2007 Outperform NS $13.80 +28.12% -23.11% +51.23
TrackBernstein 87.54 11/15/2007 Outperform NS $14.27 +23.90% -23.36% +47.25
TrackJPMorgan 84.76 10/4/2007 Outperform NS $17.21 +2.73% -27.11% +29.84
TrackDreman 93.64 9/30/2007 Outperform NS $15.96 +10.78% -26.38% +37.15 2 Comments
TrackCreditSuiss 93.62 9/10/2007 Outperform NS $15.59 +13.41% -22.97% +36.38
TrackUBS 87.99 9/10/2007 Outperform NS $15.59 +13.41% -22.97% +36.38
TrackMatrix 90.36 11/20/2006 Outperform NS $20.67 -14.48% -18.85% +4.38
TrackBofASec 94.61 8/25/2006 Underperform NS $20.50 -32.70% +12.57% +45.27 12/18/2007 @ $13.80
TrackJimCramer < 20 8/9/2006 Underperform 3W $19.75 -10.48% -10.46% +0.02

Featured Broker Partners